Laurence Reid

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence Reid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi, Inc. Director Stock Option (Right to Buy) 42K 02 Sep 2025 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17K 23 Nov 2024 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Common Stock 0 $5.03 25 Sep 2023 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (right to buy) 0 25 Sep 2023 Direct

Insider Reports Filed by Laurence Reid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGX Metagenomi, Inc. 02 Sep 2025 1 $0 4 02 Sep 2025 Director
MGX Metagenomi, Inc. 11 Aug 2025 0 $0 3 15 Aug 2025 Director
KALV KalVista Pharmaceuticals, Inc. 23 Nov 2024 1 $0 4 26 Nov 2024 Director
KALV KalVista Pharmaceuticals, Inc. 23 Nov 2024 0 $0 3 26 Nov 2024 Director
DBTX Decibel Therapeutics, Inc. 25 Sep 2023 4 $0 4 25 Sep 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. 16 Mar 2023 2 $0 4 17 Mar 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. 25 Feb 2022 1 $0 4 28 Feb 2022 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. 15 Sep 2021 1 $76.4K 4 17 Sep 2021 President and Chief Executive, Director